Skip to content
Inciteful Med

Understanding Glanzmann Thrombasthenia: The 'Bricks and Mortar' of Clotting

Last updated:

Glanzmann Thrombasthenia (GT) is a rare inherited bleeding disorder where platelets cannot stick together to form clots. Although the platelet count is normal, a genetic defect causes missing or broken "hooks" (GPIIb/IIIa receptors), leading to superficial bleeding like nosebleeds and bruising.

Key Takeaways

  • • Glanzmann Thrombasthenia is a bleeding disorder where platelets exist in normal numbers but lack the "hooks" to stick together.
  • • The condition is caused by inherited genetic mutations in the ITGA2B or ITGB3 genes that affect the GPIIb/IIIa receptor.
  • • Symptoms typically include superficial bleeding like nosebleeds, gum bleeding, and bruising rather than deep joint bleeding.
  • • GT is distinct from Hemophilia (missing clotting factors) and ITP (low platelet count) despite sharing some bleeding symptoms.

Glanzmann Thrombasthenia (GT) is a rare, inherited bleeding disorder that affects how your blood clots [1]. Unlike many other bleeding conditions where you might not have enough “bricks” to build a wall, in GT, you have plenty of bricks, but they lack the “hooks” needed to stick together [1][2].

The Bricks and Mortar of Clotting

To understand GT, it helps to imagine your body repairing a broken blood vessel like a construction crew building a wall.

  • The Bricks (Platelets): These are small cell fragments in your blood. In GT, your platelet count (the number of bricks) is typically normal [1][3]. However, these bricks are missing the “hooks” (called GPIIb/IIIa receptors) that allow them to grab onto each other [1][2].
  • The Hooks (GPIIb/IIIa): This is a protein complex on the surface of the platelet. When you are injured, these hooks “activate” or reach out to grab the mortar [4][5]. In GT, these hooks are either missing or broken because of a genetic change [6][7].
  • The Mortar (Fibrinogen): This is a protein in your blood that acts like glue. It flows between the platelets, and the hooks grab onto it to bridge the gap between “bricks” [4][8]. Without the hooks, the mortar has nothing to hold onto, and a stable wall (platelet aggregation) cannot form [9][10].

What Glanzmann Thrombasthenia Is NOT

It is common to confuse GT with other conditions, but the biology is very different:

Condition The Problem The Result
Glanzmann Thrombasthenia Broken Hooks: Normal number of platelets, but they can’t stick together [1]. Superficial bleeding (nose, gums, skin) [11][12].
Hemophilia Missing Mortar: Platelets are fine, but the body can’t make the “glue” (clotting factors) to reinforce the wall [13][9]. Deep bleeding (joints and muscles) [11][9].
ITP (Immune Thrombocytopenia) Not Enough Bricks: The immune system destroys platelets, leaving you with too few bricks to start the wall [14][15]. Bleeding due to low platelet count (<100×109/L<100 \times 10^9/L) [14][3].

Why It Happens: The Genetics of GT

GT is an autosomal recessive condition, meaning a person must inherit a changed gene from both parents to have the disorder [16][17].

  • Global Rarity: It is estimated to affect about 1 in 1,000,000 people worldwide [1][18]. However, recent studies in the U.S. suggest it might be more common, affecting roughly 1 in 350,000 people [19].
  • Population Hotspots: Because GT is recessive, it is more frequently seen in communities where consanguinity (marriage between blood relatives) is common [20][17]. High rates have been documented in parts of Saudi Arabia, Southern India, Pakistan, and Tunisia [21][20][17][16].
  • Molecular Cause: The disorder is caused by mutations in the ITGA2B or ITGB3 genes [6][22]. These mutations can cause the “hooks” to be shaped incorrectly or prevent them from ever reaching the surface of the platelet [23][24].

For more details on the specific types of GT, see the Genetics & Subtypes page.

Frequently Asked Questions

What causes Glanzmann Thrombasthenia?
GT is caused by a genetic defect that prevents platelets from making the "hooks" (GPIIb/IIIa receptors) needed to stick together. Even though the number of platelets (the "bricks") is typically normal, they cannot clump to form a stable clot.
How is Glanzmann Thrombasthenia different from Hemophilia?
In GT, the platelets are defective and can't stick together, causing superficial bleeding like nosebleeds. In Hemophilia, the platelets work fine, but the body lacks the "mortar" (clotting factors) to seal the clot, which typically causes deep bleeding in joints and muscles.
Is Glanzmann Thrombasthenia genetic?
Yes, GT is an autosomal recessive condition, meaning a person must inherit a mutated gene from both parents to have the disorder. It is seen more frequently in families where parents are related by blood (consanguinity).
Does Glanzmann Thrombasthenia cause low platelets?
No, people with GT typically have a normal platelet count. The problem is not the number of platelets, but their inability to function and stick together to stop bleeding. This distinguishes it from conditions like ITP.
What are the common symptoms of Glanzmann Thrombasthenia?
The most common symptoms are "superficial" bleeding, such as frequent nosebleeds, bleeding gums, and easy bruising. Unlike some other bleeding disorders, GT rarely causes spontaneous deep bleeding in the joints or muscles.

Questions for Your Doctor

  • • Does my (or my child's) lab work show a normal platelet count, and how does that help confirm it's GT?
  • • Is this Type I, Type II, or Type III Glanzmann Thrombasthenia based on the number of 'hooks' (GPIIb/IIIa receptors) present?
  • • What is my (or my child's) risk of developing antibodies to the GPIIb/IIIa receptor if a platelet transfusion is needed?
  • • Are there specific 'founder mutations' related to our family's ethnic or geographic background that we should know about?
  • • How do we differentiate a minor 'brick' problem (skin bruising) from a more serious bleed that requires medical intervention?

Questions for You

  • • Have I or any of my family members ever been diagnosed with a bleeding disorder, and was it a 'brick' (platelet) or 'mortar' (clotting factor) problem?
  • • Are my parents or my child's parents related by blood (consanguineous), which might explain how this recessive trait was passed on?
  • • What kind of bleeding do I notice most often: superficial (nosebleeds, gum bleeding, easy bruising) or deep (joint swelling, muscle pain)?
  • • How have my (or my child's) bleeding episodes responded to simple treatments like pressure or ice in the past?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Hemorrhage of Upper Digestive and Respiratory Tracts in a Child with Glanzmann Thrombasthenia.

    Michali M, Basiari L, Komnos I, et al.

    Maedica 2023; (18(2)):363-367 doi:10.26574/maedica.2023.18.2.363.

    PMID: 37588843
  2. 2

    Anesthetic experience for orthopedic surgery on a patient with Glanzmann's thrombasthenia refractory to platelet transfusion: A case report.

    Park JB, Shin YS, Kim SH

    Korean journal of anesthesiology 2009; (57(4)):507-510 doi:10.4097/kjae.2009.57.4.507.

    PMID: 30625914
  3. 3

    Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient.

    Ramzi M, Dehghani M, Haghighat S, Nejad HH

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(6)):688-690 doi:10.6002/ect.2014.0165.

    PMID: 26134714
  4. 4

    Using flow cytometry to monitor glycoprotein IIb-IIIa activation.

    Frelinger AL

    Platelets 2018; (29(7)):670-676 doi:10.1080/09537104.2018.1478073.

    PMID: 29799301
  5. 5

    Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans.

    Chang Y, Hsia CW, Huang WC, et al.

    Heliyon 2023; (9(10)):e20286 doi:10.1016/j.heliyon.2023.e20286.

    PMID: 37767484
  6. 6

    Novel mutations in Thai patients with glanzmann thrombasthenia.

    Ittiwut R, Suchartlikitwong P, Kittikalayawong Y, et al.

    European journal of haematology 2017; (99(6)):520-524 doi:10.1111/ejh.12965.

    PMID: 28888044
  7. 7

    Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms.

    Mutreja D, Sharma RK, Purohit A, et al.

    The Indian journal of medical research 2017; (145(5)):629-634 doi:10.4103/ijmr.IJMR_718_14.

    PMID: 28948953
  8. 8

    Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.

    Giordano A, Musumeci G, D'Angelillo A, et al.

    Current drug metabolism 2016; (17(2)):194-203 doi:10.2174/1389200217666151211121112.

    PMID: 26652157
  9. 9

    Glanzmann thrombasthenia: genetic basis and clinical correlates.

    Botero JP, Lee K, Branchford BR, et al.

    Haematologica 2020; (105(4)):888-894 doi:10.3324/haematol.2018.214239.

    PMID: 32139434
  10. 10

    New Insights Into the Treatment of Glanzmann Thrombasthenia.

    Poon MC, Di Minno G, d'Oiron R, Zotz R

    Transfusion medicine reviews 2016; (30(2)):92-9.

    PMID: 26968829
  11. 11

    Glanzmann Thrombasthenia Associated with Siderotic Synovitis and Arthropathy: A Case Report.

    Alawad MJ, Abu-Tineh M, Alshurafa A, et al.

    Journal of blood medicine 2023; (14()):563-567 doi:10.2147/JBM.S418937.

    PMID: 37941894
  12. 12

    Glanzmann thrombasthenia: a multi-center study of demographics, clinical spectrum, and treatment efficacy.

    Sherief LM, El Ekiaby M, El-Hawy M, et al.

    European journal of pediatrics 2025; (184(5)):318 doi:10.1007/s00431-025-06126-4.

    PMID: 40301132
  13. 13

    Oral Surgery in Patients With Glanzmann Thrombasthenia: A Case Series.

    Segna E, Artoni A, Sacco R, Giannì AB

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2017; (75(2)):256-259 doi:10.1016/j.joms.2016.09.048.

    PMID: 28341450
  14. 14

    Thrombocytopenia and hyperthyroidism: A case report and literature review.

    Yingchoncharoen P, Abdelnabi M, Thongpiya J, et al.

    Clinical case reports 2023; (11(10)):e7960 doi:10.1002/ccr3.7960.

    PMID: 37780929
  15. 15

    Acquired Glanzmann thrombasthenia: From antibodies to anti-platelet drugs.

    Nurden AT

    Blood reviews 2019; (36()):10-22 doi:10.1016/j.blre.2019.03.004.

    PMID: 31010659
  16. 16

    Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.

    Aloui C, Chakroun T, Granados V, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(8)):689-696 doi:10.1097/MBC.0000000000000779.

    PMID: 30325339
  17. 17

    Utility of the ISTH bleeding assessment tool (BAT) in diagnosis of Glanzmann Thrombasthenia patients.

    Saqlain N, Fateen T, Tufail H, Mazher N

    Pakistan journal of medical sciences 2022; (38(4Part-II)):791-795 doi:10.12669/pjms.38.4.5361.

    PMID: 35634602
  18. 18

    Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease.

    Doherty D, Singleton E, Byrne M, et al.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2019; (58(1)):58-60 doi:10.1016/j.transci.2018.11.008.

    PMID: 30551951
  19. 19

    Characterising Glanzmann Thrombasthenia in the United States: Real-World Data From the EPIC Cosmos Dataset.

    Citla-Sridhar D, Liu D

    Haemophilia : the official journal of the World Federation of Hemophilia 2025; doi:10.1111/hae.70170.

    PMID: 41259300
  20. 20

    Glanzmann Thrombasthenia in Children: Experience From a Tertiary Care Center in Southern India.

    Kongalappa S, Reddy JM, Durugappa T, et al.

    Journal of pediatric hematology/oncology 2019; (41(2)):e68-e71 doi:10.1097/MPH.0000000000001367.

    PMID: 30789846
  21. 21

    Gastrointestinal Bleeding/Angiodysplasia in Patients With Glanzmann Thrombasthenia.

    Tarawah RA, Tarawah AM

    Journal of medical cases 2024; (15(12)):401-405 doi:10.14740/jmc4340.

    PMID: 39610914
  22. 22

    Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients.

    Rosenberg N, Dardik R, Hauschner H, et al.

    Blood cells, molecules & diseases 2021; (89()):102560 doi:10.1016/j.bcmd.2021.102560.

    PMID: 33711653
  23. 23

    Novel compound heterozygous ITGA2B mutations in Glanzmann thrombasthenia associated with adolescent osteoporosis.

    Zhang Y, Luo Y, Zhang G

    Platelets 2026; (37(1)):2612049 doi:10.1080/09537104.2025.2612049.

    PMID: 41510763
  24. 24

    Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia.

    Wang Z, Xu Y, Sun Y, et al.

    Frontiers in pediatrics 2022; (10()):1062900 doi:10.3389/fped.2022.1062900.

    PMID: 36704147

This guide explains the biology of Glanzmann Thrombasthenia for educational purposes. Your doctor is the best source for interpreting your specific symptoms and lab results.

Stay up to date

Get notified when new research about Glanzmann Thrombasthenia is published.

No spam. Unsubscribe anytime.